Cargando…
Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods
Because of the absence of well-standardized both in-house and FDA-approved commercially available diagnostic tests, the reliable diagnosis of respiratory infection due to Mycoplasma pneumoniae remains difficult. In addition, no formal external quality assessment schemes which would allow to conclude...
Autores principales: | Loens, K., Goossens, H., Ieven, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088226/ https://www.ncbi.nlm.nih.gov/pubmed/20526788 http://dx.doi.org/10.1007/s10096-010-0975-2 |
Ejemplares similares
-
Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics
por: Loens, Katherine, et al.
Publicado: (2016) -
Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
por: Beeton, Michael L, et al.
Publicado: (2020) -
Acute Respiratory Distress Syndrome due to Mycoplasma pneumoniae Misinterpreted as SARS-CoV-2 Infection
por: Metz, Carlos, et al.
Publicado: (2021) -
Acute respiratory distress syndrome related to Mycoplasma pneumoniae infection
por: Chaabane, Nouha, et al.
Publicado: (2016) -
Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
por: Matheeussen, Veerle, et al.
Publicado: (2020)